Skip to content

Single Complete Compression Ultrasonography to Rule Out Deep Vein Thrombosis During Pregnancy and Postpartum

Diagnostic Exclusion Value of a Negative Single Distal and Proximal Lower Limb Veins Compression Ultrasonography in Pregnant and Post-partum Women With a Clinically Suspected Deep Vein Thrombosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00740454
Acronym
EDVIGE
Enrollment
200
Registered
2008-08-25
Start date
2006-01-31
Completion date
2009-04-30
Last updated
2025-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Vein Thrombosis

Keywords

pregnancy, postpartum, deep vein thrombosis, venous thromboembolism, diagnosis, compression ultrasonography

Brief summary

The objective of the EDVIGE study is to determine whether a negative single distal and proximal leg veins compression ultrasonography safely rules out the diagnosis of deep vein thrombosis in pregnant and post-partum women with clinical suspicion of DVT.

Detailed description

A single distal and proximal leg veins compression ultrasonography has been shown to safely rule out the diagnosis of DVT when negative. The safety of this strategy has never been verified in pregnant or postpartum women. It could however be limited in that clinical setting, because of modified hemodynamics, hampered observation conditions, lack of respiratory modulation, higher proportion of isolated iliac deep vein thromboses. The objective of the EDVIGE study is to assess the safety of this diagnostic strategy during pregnancy and post-partum.

Interventions

OTHERLower limb veins compression ultrasonography

Distal and proximal lower limb veins compression ultrasonography

Sponsors

Ministry of Health, France
CollaboratorOTHER_GOV
University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women with an ongoing pregnancy or within three-months post-partum and a clinically suspected deep vein thrombosis

Exclusion criteria

* suspicion of pulmonary embolism * age less than 18 years * impossible follow-up

Design outcomes

Primary

MeasureTime frame
Objectively confirmed thromboembolic events3 months

Countries

France, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026